Naturally occurring N-glycoproteins exhibit glycoform heterogeneity with respect to N-glycan sequon occupancy (macroheterogeneity) and glycan structure (microheterogeneity). However, access to well-defined glycoproteins is always important for both basic research and therapeutic purposes. As a result, there has been a substantial effort to identify and understand the catalytic properties of N-glycosyltransferases, enzymes that install the first glycan on the protein chain. In this study we found that ApNGT, a newly discovered cytoplasmic N-glycosyltransferase from Actinobacillus pleuropneumoniae, has strict selectivity toward the residues around the Asn of N-glycosylation sequon by screening a small library of synthetic peptides. The inherent stringency was subsequently demonstrated to be closely associated with a critical residue (Gln-469) of ApNGT which we propose hinders the access of bulky residues surrounding the occupied Asn into the active site. Site-saturated mutagenesis revealed that the introduction of small hydrophobic residues at the site cannot only weaken the stringency of ApNGT but can also contribute to enormous improvement of glycosylation efficiency against both short peptides and proteins. We then employed the most efficient mutant (Q469A) other than the wild-type ApNGT to produce a homogeneous glycoprotein carrying multiple (up to 10) N-glycans, demonstrating that this construct is a promising biocatalyst for potentially addressing the issue of macroheterogeneity in glycoprotein preparation.
capable of modifying polypeptides featuring sequences of eukaryotic N-glycoproteins despite no orthologous structure shared between ApNGT and OSTs, which highlights the hypothesis of convergent evolution of these two N-glycosylation systems (7) . Heterogeneous proteins such as human erythropoietin (hEPO) and cholera toxin subunit B (CtxB) have been reported to be glycosylated when co-expressed with ApNGT, suggesting a novel route for glycoengineering in bacteria (14) . In addition, the introduction of N-glycosylation sequons to increase carbohydrate content has also proved to be an effective strategy for improving properties of protein therapeutics (15, 16) . Therefore, systematic investigation of position-specific residue preference within and surrounding the Asn-X-Ser/Thr sequon would facilitate the application of ApNGT in glycoprotein production. In this study we investigated the preference feature of ApNGT by screening three panels of synthetic peptide substrates and found a critical residue (Gln-469) being closely associated with the stringency of ApNGT. Site-saturated mutagenesis at this site gave rise to a series of valuable mutants with significantly enhanced glycosylation efficiency and expanded acceptor specificity. The most efficient mutant (Q469A) was successfully used for the preparation of homogeneous glycoprotein carrying multiple (up to 10) N-glycans, whereas the wild-type ApNGT produced heterogeneous glycoprotein.
Results

Investigation of position-specific residue preference of ApNGT
The residue preference within and surrounding the N-glycosylation sequon (position Ϫ1, ϩ1, and ϩ3) was investigated by screening three panels of synthetic peptide substrates in a systematic manner. For each position, at least five representative amino acids containing basic, acidic, hydroxyl, small hydrophobic, or aromatic side chains were evaluated. As shown in Fig. 1 , A and B, both acidic residues and basic residues are disfavored for ApNGT at either the Ϫ1 or ϩ1 position, whereas basic residues are particularly preferred at the ϩ3 position. Also, residues with small side chains are relatively preferred at positions Ϫ1 and ϩ1. Unexpectedly, the peptide with Gly at ϩ1 position nearly abolished glycosylation. In light of the investigation, a shortest optimal sequence motif recognized by ApNGT would be given as "ANVTK." Further investigation showed that only the peptide optimized at all three positions (containing the optimal motif) could achieve the maximum glycosylation (supplemental Fig. S1 ).
Gln-469 contributes to acceptor specificity
Structural alignment of ApNGT and XcOGT, which share the closely related GT-B domains, showed that an extended loop-connecting sheet ␤10 and helix ␣19 (L ␤10␣19 ) sticks out toward UDP complexed with ApNGT ( Fig. 2A ). Residues Gln-469 within L ␤10␣19 and His-277 are structurally adjacent to each other and form the narrow "neck" of the acceptor binding funnel. Because the pair of residues locates above the UDP-binding site, the narrow entryway formed by them might block the access of amino acids with bulky side chains into the active site and thus plays a role in determining the residue preference surrounding the Asn of N-glycosylation sequons. His-277, which is conserved across all GT41 family members (classification according to CAZy database; Ref. 17) , has been proposed to be involved in catalysis. The replacement of His-277 with Ala resulted in loss of ϳ95% catalytic activity (8) . However, the mutation of Gln-469 to Ala led to an ϳ100-fold increase in the turnover rate constant (k cat ) and an ϳ162-fold increase in the catalytic efficiency (k cat /K m ) against a peptide GGFNLTY-TIER (supplemental Table S1 ). We next explored the residue preference feature of Q469A in the same manner as done for the wild-type ApNGT previously. As shown in Fig. 1 , the mutant Q469A and the wild-type ApNGT show a similar preference toward charged residues at all three positions, whereas the former exhibits better tolerance at both the Ϫ1 and ϩ1 positions for residues harboring the bulky side chain, such as Leu, Phe, and the acylated Lys at the Ϫ1 position as well as Ile and Leu at the ϩ1 position. In addition, the mutant Q469A exhibits better tolerance toward the Gln-X-Ser/Thr sequon (supplemental Fig. S2, A and B) , which has been reported to be glycosylated by the wild-type ApNGT at an extremely low rate (Ͼ15,000-fold reduction in turnover rate as compared with Asn-X-Ser/Thr; Ref. 7) . 
Site-saturated mutagenesis
To fully understand the role of Gln-469 in catalysis and determination of acceptor specificity, site-saturated mutagenesis was performed at this critical site. Finally, 17 mutants were successfully constructed, except two mutants (Q469M and Q469R) that were not expressed in Escherichia coli. The relative activity of the variants was assessed against a synthetic peptide containing the optimal motif ANVTK. The residue preference around the N-glycosylation site for each mutant was also probed in single catalytic system against multiple peptides in one pot (multipeptide one-pot). The glycosylated product profile was then analyzed by MALDI-TOF mass spectrometry. As we expected, the replacement of the target glutamine with small hydrophobic amino acids, such as Gly, Ala, Val, Ile, and Leu, resulted in more flexible residue selectivity at Ϫ1 and ϩ1 positions ( Table 1) . Given that the mutant Q469A and the wild-type enzyme share the exact same residue preference at ϩ3 position of the Asn-X-Ser/Thr sequon (Fig. 1C ), the apparent difference of preference at the ϩ3 position revealed by these variants was probably due to their different catalytic efficiency. To our surprise, most ApNGT variants including the wild-type enzyme showed comparable activity against a peptide (GGANVTKTIER) containing the optimal motif ANVTK, although the mutant Q469A is most efficient (Fig. 3 ).
Protein glycosylation
To compare the catalytic efficiency of the wild-type ApNGT and the mutant Q469A, which is the most efficient N-glycosyltransferase obtained in this study ( Fig. 3 ), in protein glycosylation, a soluble fragment corresponding to amino acids 1205-1536 of a mature HMW1 adhesin (HMW1ct) was employed as a protein acceptor. HMW1 mediates adherence to respiratory epithelial cells and undergoes heavy N-glycosylation at 31 different sites (18) . HMW1ct carries 12 Asn-X-Ser/Thr sequons (Fig. 4A ), and 3 of them (AANVT P5 LNTT P6 GT and NINATSG P7 ) have been identified as the modification sites of ApNGT (19) . We first assessed whether the wild-type ApNGT and the mutant Q469A are capable of modifying all the potential N-glycosylation sites. As shown in Fig. 5 , A-D, the mutant Q469A catalyzed much more productive glycosylation as expected. However, uniform glycoform could not be produced by both isoforms no matter by raising the ratio of enzyme to acceptor protein or elongating the reaction time.
To find out which sites are incompetent, site-directed mutagenesis was used to generate 12 mutants from a previously synthesized template that carries 12 inactive sequons with the 
Table 1 The effect of substitutions at Gln-469 on the preference profile of ApNGT
The same amount of enzymes (1.4 M) was used for all assays. Three sets of mixed peptides used were (GG[G/A/S/V/L/D/K/F]NLTYTIER, GGSN[G/A/S/P/V/L/D/ K/F]TYTIER and GGSNLT[A/S/D/K/R/Y]TIER). Ϫ, products were not detected.
Mutants
Residue preference at various positions
Gly Ala Ser Val Leu Phe Val Leu Phe Ala Ser Lys Arg Tyr Q469A
Gly Ala Ser Val Leu Phe Ala Ser Val Leu Phe Ala Ser Lys Arg Tyr Q469V
Ala Ser Leu Ala Ser Val Leu Phe Ala Ser Lys Arg Tyr Q469I
Ϫ Ala Val Phe Lys Q469L
Ϫ Asn substituted by Ala. Each mutant bears a single Asn-X-Ser/ Thr sequon. Finally, we detected five incompetent sequons (EANVTSA P1 , QVNLSAQ P4 , NANGSGS P10 , RVNITGD P11 , and EPNNTIT P12 ). As shown in Fig. 4B , mutant acceptors carrying P1, P4, P11, and P12 sequons were not glycosylated by the mutant Q469A at all, although that carrying P10 was partially glycosylated. Because charged residues are found in P1 (Glu at the Ϫ2 position) and P11 (Arg and Asp at the Ϫ2 and ϩ4 positions, respectively) sites, the residue preference at these two distal positions (Ϫ2 and ϩ4) was further explored in a multipeptide one-pot manner as described above. As shown in the supplemental Fig. S3 , significant inhibition of charged, aromatic, and bulky uncharged residues was not observed at Ϫ2 and ϩ4 positions for the Q469A mutant. According to this discovery, the inefficiency of P1 (EANVTSA) and P11 (RVNITGD) might lead from some undesired secondary structures. By contrast, proline, and asparagine and glycine are disfavored at the Ϫ1 and ϩ1 positions, respectively, by both the mutant Q469A and the wild-type enzyme (Fig. 1, A and B) . Also, the threonine has been reported to be much preferred (Ͼ10fold) by ApNGT, as opposed to serine, in position ϩ2 (7) . Thus, the potential N-glycosylation sites of P4 (QVNLSAQ), P10 (NANGSGS), and P12 (EPNNTIT) could be further optimized to enhance the glycosylation level. After the five incompetent sites (P1, P4, P10, P11, and P12) were eliminated by converting the Asn of Asn-X-Ser/Thr sequons to Ala, the Q469A-catalyzed glycosylation yielded a uniform glycoprotein as shown in Fig. 5E . We next optimized the sequons of P4, P10, and P12 by replacing five disfavored residues with the preferred ones (QVNLTAQ P4Ј , NANVTGS P10Ј , and EANVTIT P12Ј ) in which and P1 and P11 remained inactive. Ultimately, a homogeneous glycoprotein carrying up to 10 N-glucoses was produced by using the mutant Q469A (Fig. 5F) . In contrast, the wild-type ApNGT could not fulfill the uniform glycosylation for proteins bearing multiple N-glycosylation sequons. In comparison with Q469A, several Q469A (B) . Site-directed mutagenesis was used to generate 12 mutants (P1-P12) from a previously synthesized template carrying 12 inactive sequons with the Asn substituted by Ala. Each mutant has a single Asn-X-Ser/Thr sequon. Protein glycosylation was analyzed by MALDI-TOF mass spectrometry. Acceptor proteins and the potential products were labeled with gray lines and colored lines, respectively. The matrix adduct ion appears to be the addition of a matrix molecule to the protein ions with an accompanying loss of water (37, 38) .
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mutants, such as Q469G and Q469V, also exhibited analogous efficiency against HMW1ct beyond relatively flexible acceptor selectivity (supplemental Fig. S4 and Table 1 ).
Donor specificity of the mutant Q469A
Although Gln-469 structurally positions close to the UDP moiety and has been reported to make hydrogen-bond interactions with one phosphate group of UDP (via a water molecule) (8), the mutant Q469A possesses quite similar donor specificity to the wild-type ApNGT (active to both UDP-Glc and UDP-Gal but not their acetylated derivatives; data not shown).
Residue preference feature of known N-glycoproteins in the PDB database
Based on the amino acid composition analysis of a set of 2250 non-redundant N-glycan sites from 1433 glycoproteins in the Protein Data Bank crystallographic database (20) , charged residues were found in quite low abundance at the positions adjacent to the occupied Asn (Ϫ1 and ϩ1), although a strong preference for any single residue was not observed (Fig. 6 ). Because the mutant Q469A also dislikes sequons harboring charged residues at Ϫ1 and ϩ1 positions, the most known N-glycan sites could be well-tolerated by Q469A.
Discussion
In this study the systematic investigation of position-specific residue preference within and around the N-glycan sequon indicated that ApNGT has strict specificity for residues especially at the Ϫ1 and ϩ1 positions. The optimal N-glycosylation motif recognized by ApNGT (ANVTK) is unexpectedly similar to a previously reported one (PYNVTK) preferred by an archaeal OST from Pyrococcus furiosus particularly at positions ϩ1 and ϩ3 (21) . Because the NGT involved N-glycosylation system has been proposed to evolved independently (22) , it remains mysterious how ApNGT and the archaeal OST have such a similar residue preference feature. More interestingly, NGTs from either ␤or ␥-proteobacteria seem not to evolve independently of each other, suggesting that horizontal gene transfer might occur between the two classes (supplemental Fig. S5 ).
Gln-469, whose side chain sways into the UDP-binding pocket and forms the narrow neck of the acceptor-binding funnel with His-277, was herein established to be involved in determining the acceptor specificity of enzyme. The introduction of small hydrophobic residues at Gln-469, such as Gly, Ala, and Val, not only weakened the stringency of ApNGT but also contributed to an enormous improvement of glycosylation efficiency against both peptides and proteins. A plausible hypothesis is that the substitutions can facilitate the accommodation of peptides/proteins into the active site and thereby enhanced the turnover rate constant. The deduction can also be supported by the observation that a very short peptide (SNLTY) was well-glycosylated by the mutant Q469A instead of the wildtype ApNGT (supplemental Fig. S2, C and D) . On the other hand, it is not difficult to understand why most ApNGT variants including the wild-type enzyme and even Q469F and Q469Y can well accept a peptide (GGANVTKTIER) containing the optimal motif ANVTK with small residues Ala and Val at the Ϫ1 and ϩ1 positions, respectively (Fig. 3) . In contrast to bacterial OSTs, which regulate acceptor specificity by requiring an additional acidic residue at Ϫ2 position, ApNGT evolved 
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(relatively strict) selectivity by recruiting a critical residue (Gln-469) within the catalytic site. In addition, the introduction of variant residues at Gln-469 of ApNGT is structurally feasible, but exchange of the loop (L ␤10␣19 ) with the corresponding fragment of XcOGT resulted in a completely inactive protein (data not shown), suggesting that the unique loop might be required for substrate binding and/or structure maintaining.
Further inspection of the potential acceptor-binding site of ApNGT revealed that residues of Phe-39 and His-272 introduce bulky bumps in the van der Waals surface of the funnelshaped groove. Although the "bump-and-hole" strategies have been successfully applied for retuning the selectivity of proteins and protein-ligand engineering (23) (24) (25) , replacement of them with a smaller alanine was previously demonstrated to decrease the enzyme activity to various extents (8) .
Naturally occurring N-glycoproteins usually exhibit glycoform heterogeneity with respect to N-glycan sequon occupancy (macroheterogeneity) and glycan structure (microheterogeneity) (26 -28) . In recent years great efforts have been made for preparation of glycan-defined glycoproteins including in vivo glycoengineering and in vitro chemical or chemoenzymatic synthesis (28 -34) . Additionally, introducing extra N-linked glycosylation sites into therapeutic proteins, such as erythropoietin, has also been proven to improve their serum half-life and therapeutic efficiency (35) . In this study the engineered Q469A (the most efficient mutant) has been proven to efficiently modify proteins with multiple N-glycosylation sites and, therefore, presents a promising biocatalyst for potentially addressing the issue of glycoprotein macroheterogeneity. Meanwhile, sequonoptimization was also demonstrated to be a useful strategy for the generation of uniform glycoprotein. Moreover, the relatively extended acceptor selectivity of the mutant Q469A would allow fewer alterations toward acceptor proteins for reaching uniform glycosylation.
On the other hand, inaccessible Asn-X-Ser/Thr sequon or nearby exceptional secondary structures will obviously inhibit the glycosylation. For example, incompetent P1 and P11 sites probably resulted from structural elements because no disfavored residues are found at Ϫ1, ϩ1, and ϩ3 positions. There-fore, known the three-dimensional structure would greatly benefit the N-glycosylation site engineering either for modifying an existing Asn-X-Ser/Thr sequon or inserting a new one.
Taken together, Gln-469, which is conserved in NGTs of subgroup 2 (supplemental Fig. S6 ), was demonstrated to be a critical amino acid for ApNGT to maintain its stringency. Introduction of small hydrophobic residues at the site has created a series of efficient mutants with expanded selectivity on Asn-X-Ser/Thr sequon. Because signals that control the efficiency of N-linked glycosylation at individual Asn residues have not been fully defined, efficient N-glycosylation machines, such as the mutant Q469A, are always valuable for either in vivo or in vitro glycosylation methods. Additionally, this is the first report that homogeneous glycoprotein carrying multiple (up to 10) N-glycans were in vitro enzymatically prepared.
Experimental procedures
Materials UDP-Glc and UDP-Gal used were purchased from Sigma. UDP-GlcNAc and UDP-GalNAc were enzymatically synthesized as previously described (36) .
Cloning and mutant construction
apNGT was cloned from genomic DNA of A. pleuropneumoniae ATCC 27088D (purchased from ATCC, Manassas, VA) and then cloned into pET15b. hMW1ct and its isoform bearing 12 inactive Asn-X-Ser/Thr sequons with the Asn substituted by Ala were codon-optimized (for the E. coli expression system) and synthesized by Genewiz (Suzhou, China). Mutagenesis was performed using a fast site-directed mutagenesis kit (Trans-Gen, Beijing, China). All mutations were confirmed by DNA sequencing.
Expression and purification of recombinant proteins
The E. coli BL21 (DE3) strains, transformed with the corresponding expression plasmids, were cultured in LB medium supplemented with ampicillin (100 g ml Ϫ1 ). Overexpression of the target protein was achieved by inducing the E. coli culture Figure 6 . Amino acid preferences in occupied N-glycan sites. 1433 glycoproteins containing N-linked GlcNAc were retrieved from the PDB database by using a web-based glycan searching tool (Glycan Modeling and Stimulation). Total 2250 non-redundant N-glycan sites derived from these glycoproteins were identified by using pdb2linucs (39) and used to generate the sequence logo with WebLogo (40) . Neighboring residues located downstream (positions ϩ1 to ϩ5) and upstream (positions Ϫ1 to Ϫ3) from the occupied asparagine residue (position 0) are shown. The size of each letter represents the residue prevalence at the putative position.
Engineering a cytoplasmic N-glycosyltransferase with 0.1 mM isopropyl-␤-D-thiogalactopyranoside (IPTG) when the A 600 reached 0.8 followed by incubating at 18°C for 20 h. The cells were harvested by centrifugation at 6000 ϫ g for 10 min, resuspended in 100 mM Tris-HCl buffer (pH 8.0), and broken by sonication. After centrifugation (13,523 ϫ g, 20 min) of the cell lysate, the supernatant was applied onto a Ni 2ϩnitrilotriacetic acid affinity column (Qiagen, Hilden, Germany). The column was pre-equilibrated with 8 column volumes of binding buffer (5 mM imidazole, 0.5 M NaCl, and 20 mM Tris-HCl (pH 8.0)) before the lysate was loaded. After washing with 8 column volumes of washing buffer (50 mM imidazole, 0.5 M NaCl, and 20 mM Tris-HCl (pH 8.0)), the target protein was eluted with elution buffer (200 mM imidazole, 0.5 M NaCl, and 20 mM Tris-HCl (pH 8.0)). Elution fractions were analyzed by 12% SDS-PAGE and Coomassie staining. The concentration of purified enzymes was obtained using a BCA Protein Assay kit (Pierce) with bovine serum albumin as a protein standard.
Peptide synthesis
Wang resin (GL Biochem, Shanghai, China) (1 g) was swelled with DCM (10 ml) for 30 min. L-Arg (L-type arginine) (1 mmol eq), DIC (1 mmol), and 4-dimethylaminopyridine (1 mmol) in DMF (10 ml) were added to the resin and bubbled with N 2 for 3 h. Then pyridine (1 ml) and acetic anhydride (1 ml) were added and removed after 30 min. The resin was washed with DCM and DMF. The protecting group Fmoc was removed subsequently by 20% piperidine in DMF (monitored by a ninhydrin test). The second amino acid L-Glu (3 mmol), 1-hydroxybenzotriazole (3 mmol), and DIC (3 mmol) were added to the resin and bubbled with N 2 for 1 h. The resin was washed with DCM and DMF (monitored by the ninhydrin test; no blue appeared), whereupon the remaining amino acids were added sequentially repeating the above steps. Acp (6-aminocaproic acid) (3 mmol), 1-hydroxybenzotriazole (3 mmol), and DIC (3 mmol) in DMF were added and bubbled with N 2 for 1 h. Then FITC (3 mmol) and ethyldiisopropylamine (3 mmol) in DMF were added and bubbled with N 2 for 4 h (monitored by the ninhydrin test; no blue appeared). At last, 95% TFA in water was added and oscillated for 2 h to give the crude peptide product. Purification by preparative HPLC afforded target compound (purity Ն98%) following by lyophilization to give a pale yellow solid powder ultimately.
Enzymatic assays for glycosylation of peptides and proteins
For systematic investigation of position-specific residue preference within and surrounding N-glycan sequon, assays were performed in a total volume of 30 l containing 1 mM concentrations of various peptides, 20 mM UDP-Glc, 9.2 M ApNGT (wild type), or a 0.4 M concentration of mutant Q469A and buffered with 50 mM Tris-HCl (pH 8.0) at 37°C for 45 min. Reactions were then stopped by the addition of 20 l of glycine stop solution (pH 10.6) and analyzed by reverse phase HPLC (RP-HPLC, Phenomenex Aeris PEPTIDE 3.6 m XB-C18, 250 ϫ 4.6-mm column, gradient elution from 14 -42% acetonitrile over 30 min). Glycosylated peptides were further identified by mass spectrometry, which was performed on an Autoflex III TOF/TOF200 mass spectrometer (Bruker Daltonics, Leipzig, Germany). Apparent kinetic parameters were obtained by varying the concentration of FITC-labeled peptide from 5 to 80 M and keeping the UDP-glucose concentration fixed (20 mM). The FITC-labeled peptide/glycopeptide was detected by excitation at 495 nm and emission at 520 nm. All assays were carried out in duplicate, and the data were fitted into the Michaelis-Menten equation using Grafit 6.0 (Erithacus Software Ltd). Multipeptide one-pot assays were carried out in 50 mM Tris-HCl (pH 8.0) containing a 1 mM mixture of various peptides, 20 mM UDP-Glc, and 1.4 M enzyme at 37°C for 45 min. The glycosylated product profile was analyzed by MALDI-TOF mass spectrometry. 10 mg ml Ϫ1 ␣-cyano-4-hydroxy-cinnamic acid (Sigma) was used as the matrix and premixed with samples in a ratio of 1:1 (v/v).
The assays for glycosylation of proteins were performed in a total volume of 200 l containing 12.8 M various HMW1ct derivatives, 5 mM UDP-Glc, appropriate amounts of ApNGT (WT), or the mutant Q469A and buffered with 50 mM Tris-HCl (pH 8.0). Glycosylated products were analyzed by mass spectrometry, which was performed on an AutoflexIII LRF200-CID mass spectrometer (Bruker Daltonics). Samples were concentrated using centrifugal ultrafiltration devices (Amicon Ultra 0.5 ml Centrifugal Filters, Merck-Millipore). 10 mg ml Ϫ1 sinapinic acid (Sigma) was used as the matrix and premixed with samples in a ratio of 1:1 (v/v).
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